Manila [Philippines], August 13 (ANI/Sputnik): Phase 3 clinical trials of the Russian COVID-19 vaccine will be held in the Philippines from October to March, Philippine presidential spokesperson Harry Roque said on Thursday.
Mumbai (Maharashtra) [India], Aug 12 (ANI): Equity benchmark indices erased early losses but lay flat in the negative terrain at close on Wednesday with pharma stocks remaining under pressure.
Mumbai (Maharashtra) [India], Aug 12 (ANI): Equity benchmark indices drifted lower during early hours on Wednesday amid weak global cues with pharma stocks losing the most.
Bengaluru (Karnataka) [India], Aug 10 (ANI/NewsVoir): Bangalore based Atrimed Pharma, a pioneer in developing scientifically-tested plant-based medication, has organised Lecture Series by experts An Hour with an Expert - named "AtrimedX Platform" which will be covered in forthcoming six mont
Mumbai (Maharashtra) [India], Aug 10 (ANI): The Indian government's recent incentives to boost domestic manufacturing of active pharmaceutical ingredients (APIs) and key starting materials (KSMs) can improve backward integration over the next few years and curtail supply-chain disruption ris
Mumbai (Maharashtra) [India], Aug 10 (ANI): Equity benchmark indices advanced by 0.8 per cent during early hours on Monday with pharma, auto and financial stocks in the lead.
Washington [USA], Aug 7 (ANI): US President Donald Trump has signed an executive order directing some federal agencies to prioritise purchasing certain drugs and medical materials when made in the United States.
Mumbai (Maharashtra) [India] Aug 7 (ANI/PRNewswire): Alembic Pharmaceuticals, a Vadodara headquartered company, is a leading manufacturer of pharmaceuticals with three business verticals -International generics (approximately 58 per cent), Domestic branded formulations (approximately 31 per
Mumbai (Maharashtra) [India], Aug 6 (ANI): Glenmark Pharmaceuticals will introduce a 400 mg version of oral anti-viral FabiFlu for the treatment of mild to moderate Covid-19 in India.
Mumbai (Maharashtra) [India], Aug 5 (ANI): Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19.
Mumbai (Maharashtra) [India], Aug 4 (ANI): Sun Pharmaceutical Industries said on Tuesday it has launched Favipiravir (200 mg) in India under the brand FluGuard at an economical price of Rs 35 per tablet for the treatment of mild to moderate cases of COVID-19.
Visakhapatnam (Andhra Pradesh) [India], Aug 4 (ANI): A fire broke out outside a pharma company in Andhra Pradesh's Visakhapatnam district on Tuesday morning. No injuries have been reported in the incident.